Recombinant CD3 (Teplizumab Biosimilar) antibody
This Humanized Monoclonal antibody specifically detects CD3 (Teplizumab Biosimilar) in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN7538084
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant CD3 (Teplizumab Biosimilar) antibody (ABIN7538084)
Target
CD3 (Teplizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Monoclonal
Conjugate
This CD3 (Teplizumab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Teplizumab Biosimilar - Anti-CD3 mAb - Research Grade
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- CD3 (Teplizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
- Teplizumab (MGA-031) is a Fc receptor non-binding anti-human CD3 monoclonal antibody. Teplizumab reduces the loss of beta-cell function. Teplizumab can be used in the research of type 1 diabetes.
-
CAS-No
- 876387-05-2
Target
-
You are here:
